Erasca Newsroom

Jefferies Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $6

Futu NewsNov 19 16:39

Erasca Initiated at Buy by Jefferies

Dow JonesNov 18 20:25

Erasca Analyst Ratings

BenzingaNov 18 20:15

Bank of America Securities Sticks to Its Hold Rating for Erasca (ERAS)

TipRanksNov 15 22:34

BofA Securities Maintains Erasca(ERAS.US) With Hold Rating

Futu NewsNov 15 22:33

Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 13 21:31

H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 13 20:35

HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target

BenzingaNov 13 20:14

Erasca's Innovative Naporafenib Shows Promise in NRAS-mutant Melanoma, Garnering Buy Rating From Analyst

TipRanksNov 13 19:51

A Quick Look at Today's Ratings for Erasca(ERAS.US), With a Forecast Between $4 to $6

Futu NewsOct 25 21:10

Erasca's Promising Developments and Positive Outlook Justify Buy Rating

TipRanksOct 25 18:21

Goldman Sachs Maintains Buy on Erasca, Lowers Price Target to $3

BenzingaAug 14 23:53

Erasca Analyst Ratings

BenzingaAug 14 02:14

HC Wainwright & Co. Maintains Buy on Erasca, Raises Price Target to $6

BenzingaAug 14 02:14

Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials

TipRanksAug 14 01:37

Goldman Sachs Maintains Erasca(ERAS.US) With Buy Rating, Cuts Target Price to $3

Futu NewsAug 14 01:32

Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Cuts Target Price to $4

Futu NewsAug 13 20:33

Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)

TipRanksAug 13 20:23

H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Raises Target Price to $6

Futu NewsAug 13 18:31

Erasca's Innovative Melanoma Treatments Prompt Buy Rating

TipRanksAug 13 18:22